Home
|
Press
|
Events
|
Eshare
Sign in
/
Register
0
Shopping Cart
X
Close
My Products (0 items)
My shopping cart is empty.
.
Sign in
/
Register
X
Close
Login/Register
Email
Password
INDUSTRIES
Agriculture
Chemicals
Food & Feed
Pesticides
Titanium Dioxide (TiO2)
Dairy Products
Full Industry List
ONLINE DATABASE
PRICE FORECAST
PRODUCTS & SERVICE
Products' Introduction
Industrial Reports
Newsletters
Market Data
Content Byte
Agrochemical Regulatory
Customized solutions
IMPACT FACTOR
MARKET NEWS
Agriculture
Chemicals
Food & Feed
Other
ABOUT
About CCM
Why CCM?
CCM Story
CCM Clients
Events
Career
Company news
CONTACT
Home
Product
Newsletters
>
NMN projects of Yikelai Pharmaceutical and Kangjie Biotechnology pass EIA
Read online
NMN projects of Yikelai Pharmaceutical and Kangjie Biotechnology pass EIA
Summary: Two NMN projects passed EIA — Yikelai Pharmaceutical's technology upgrading project of 100 t/a sitagliptin, 100 t/a nicotinamide mononucleotide (NMN) and 90 t/a 2-R-BOC-butyric acid, and Kangjie Biotechnology's expansion project of 20 ...
Vitamins China E-News 202108
Add to DIY report
Select whole article
I haven't create reports,
create a new report
right now!
Recommend Newsletters
Crop Farming in China
2016/05/31
More>>
Report on Glyphosate Business Opportunities Worldwide
2016/07/27
More>>
Specialised Control and Prevention of Pests and Diseases for Crops in China
2016/07/12
More>>
Loading...